Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Debt (2019 - 2025)

Mimedx (MDXG) has disclosed Non-Current Debt for 9 consecutive years, with $16.5 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 7.64% to $16.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.5 million through Dec 2025, down 7.64% year-over-year, with the annual reading at $16.5 million for FY2025, 7.64% down from the prior year.
  • Non-Current Debt hit $16.5 million in Q4 2025 for Mimedx, down from $16.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $49.0 million in Q3 2023 to a low of $16.5 million in Q4 2025.
  • Historically, Non-Current Debt has averaged $36.0 million across 5 years, with a median of $48.0 million in 2021.
  • Biggest five-year swings in Non-Current Debt: increased 1.01% in 2023 and later crashed 63.2% in 2024.
  • Year by year, Non-Current Debt stood at $48.1 million in 2021, then grew by 0.97% to $48.6 million in 2022, then decreased by 1.02% to $48.1 million in 2023, then crashed by 62.93% to $17.8 million in 2024, then decreased by 7.64% to $16.5 million in 2025.
  • Business Quant data shows Non-Current Debt for MDXG at $16.5 million in Q4 2025, $16.8 million in Q3 2025, and $17.2 million in Q2 2025.